New developments in treating glycosphingolipid storage diseases.

Míreanna comhchosúla

• Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
  de réir: Jeyakumar, M, et al.
  Foilsithe / Cruthaithe: (2002)
• New therapeutics for the treatment of glycosphingolipid lysosomal storage diseases.
  de réir: Butters, T, et al.
  Foilsithe / Cruthaithe: (2003)
• Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders.
  de réir: Butters, T, et al.
  Foilsithe / Cruthaithe: (2000)
• Substrate deprivation: a new therapeutic approach for the glycosphingolipid lysosomal storage diseases.
  de réir: Platt, F, et al.
  Foilsithe / Cruthaithe: (2000)
• N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
  de réir: Andersson, U, et al.
  Foilsithe / Cruthaithe: (2000)